CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-31 | DRISCOLL FREDERICK W Director | Grant or award · Stock option (right to buy) | +10,000 | 10,000 | ||
| 2017-05-31 | NEIS JOHN Director | Grant or award · Stock option (right to buy) | +10,000 | 10,000 | ||
| 2017-05-31 | Loren Stefan Director | Grant or award · Stock option (right to buy) | +10,000 | 10,000 | ||
| 2017-05-31 | Swirsky Douglas J Director | Grant or award · Stock option (right to buy) | +10,000 | 10,000 | ||
| 2017-04-18 | Kolean Chad J VP, Chief Financial Officer | Grant or award | +80,000 | 80,000 | ||
| 2017-04-18 | Longcor Jarrod Sr. VP of Corp Dev & Ops | Grant or award | +80,000 | 80,000 | ||
| 2017-04-18 | CARUSO JAMES V President and CEO | Grant or award | +200,000 | 247,548 | ||
| 2017-04-17 | Friend John E. II VP, Chief Medical Officer | Grant or award | +100,000 | 100,000 | ||
| 2016-11-29 | NEIS JOHN Director | Purchase | +333,333 | $1.49 | $497K | 631,317 |
| 2016-11-29 | NEIS JOHN Director | Purchase · Series C Warrants (right to buy) | +333,333 | $0.01 | $3K | 607,946 |
| 2016-10-31 | Hertzberg Richard significant owner | Sale | −21,000 | $2.03 | $43K | 280,000 |
| 2016-08-09 | Hertzberg Richard significant owner | Sale · Cellectar Biosciences Inc. Warrant (CLRBW) | −40,916 | $1.75 | $72K | 0 |
| 2016-07-15 | Longcor Jarrod Sr. VP of Corp Dev & Ops | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2016-07-05 | Loren Stefan Director | Grant or award · Stock option (right to buy) | +22,500 | $0.01 | $225 | 23,500 |
| 2016-07-05 | HILL STEPHEN A Director | Grant or award · Stock option (right to buy) | +22,500 | $0.01 | $225 | 25,434 |
| 2016-07-05 | NEIS JOHN Director | Grant or award · Stock option (right to buy) | +22,500 | $0.01 | $225 | 24,750 |
| 2016-05-12 | CARUSO JAMES V President and CEO | Grant or award · Stock option (right to buy) | +200,000 | $0.01 | $2K | 237,500 |
| 2016-05-12 | Weichert Jamey P Chief Scientific Officer | Grant or award · Stock option (right to buy) | +40,000 | $0.01 | $400 | 42,895 |
| 2016-05-12 | Kolean Chad J VP, CFO and Treasurer | Grant or award · Stock option (right to buy) | +50,000 | $0.01 | $500 | 52,000 |
| 2016-04-21 | Hertzberg Richard Significant Owner | Purchase | +3,758 | $1.90 | $7K | 301,000 |
Page 8 of 12 · 229 trades